INCB099280
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for INCB099280, covering 2025-07-14 to 2026-06-04. Get the full timeline:
Most recent: Clinical Trial Results: A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors [Phase 1, Phase 2]